Milestone Pharmaceuticals is trading at $0.74, with a -6.73% change; no clear catalyst for the decline is established.
- No company-specific announcement was found for October 16, 2026. Recent European trial enrollment and China regulatory approval were announced earlier and do not explain this session’s decline.
- Broader indexes are lower and may be contributing to risk-off sentiment, while healthcare is reported higher.